» Articles » PMID: 24288545

DNA Methylation Changes During In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2013 Nov 30
PMID 24288545
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) hold great promise for the treatment of numerous diseases. A major problem for MSC therapeutic use is represented by the very low amount of MSCs which can be isolated from different tissues; thus ex vivo expansion is indispensable. Long-term culture, however, is associated with extensive morphological and functional changes of MSCs. In addition, the concern that they may accumulate stochastic mutations which lead the risk of malignant transformation still remains. Overall, the genome of human MSCs (hMSCs) appears to be apparently stable throughout culture, though transient clonal aneuploidies have been detected. Particular attention should be given to the use of low-oxygen environment in order to increase the proliferative capacity of hMSCs, since data on the effect of hypoxic culture conditions on genomic stability are few and contradictory. Furthermore, specific and reproducible epigenetic changes were acquired by hMSCs during ex vivo expansion, which may be connected and trigger all the biological changes observed. In this review we address current issues on long-term culture of hMSCs with a 360-degree view, starting from the genomic profiles and back, looking for an epigenetic interpretation of their genetic stability.

Citing Articles

High yield engineered nanovesicles from ADSC with enriched miR-21-5p promote angiogenesis in adipose tissue regeneration.

Sun D, Mou S, Chen L, Yang J, Wang R, Zhong A Biomater Res. 2022; 26(1):83.

PMID: 36528594 PMC: 9758932. DOI: 10.1186/s40824-022-00325-y.


Decidualization Potency and Epigenetic Changes in Human Endometrial Origin Stem Cells During Propagation.

Valatkaite E, Bausyte R, Vitkeviciene A, Ramasauskaite D, Navakauskiene R Front Cell Dev Biol. 2021; 9:765265.

PMID: 34869358 PMC: 8640123. DOI: 10.3389/fcell.2021.765265.


What Molecular Recognition Systems Do Mesenchymal Stem Cells/Medicinal Signaling Cells (MSC) Use to Facilitate Cell-Cell and Cell Matrix Interactions? A Review of Evidence and Options.

Hart D Int J Mol Sci. 2021; 22(16).

PMID: 34445341 PMC: 8395489. DOI: 10.3390/ijms22168637.


DNMT3B Is an Oxygen-Sensitive De Novo Methylase in Human Mesenchymal Stem Cells.

Dogan F, Aljumaily R, Kitchen M, Forsyth N Cells. 2021; 10(5).

PMID: 33925659 PMC: 8145390. DOI: 10.3390/cells10051032.


DNA methylation biomarkers for nasopharyngeal carcinoma.

Han B, Yang X, Zhang P, Zhang Y, Tu Y, He Z PLoS One. 2020; 15(4):e0230524.

PMID: 32271791 PMC: 7144954. DOI: 10.1371/journal.pone.0230524.


References
1.
Chen P, Yen M, Liu K, Sytwu H, Yen B . Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci. 2011; 18:49. PMC: 3156728. DOI: 10.1186/1423-0127-18-49. View

2.
Schellenberg A, Lin Q, Schuler H, Koch C, Joussen S, Denecke B . Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY). 2011; 3(9):873-88. PMC: 3227452. DOI: 10.18632/aging.100391. View

3.
Teschendorff A, Menon U, Gentry-Maharaj A, Ramus S, Weisenberger D, Shen H . Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010; 20(4):440-6. PMC: 2847747. DOI: 10.1101/gr.103606.109. View

4.
Zhang L, Peng L, Wu N, Li L . Development of bone marrow mesenchymal stem cell culture in vitro. Chin Med J (Engl). 2012; 125(9):1650-5. View

5.
Wang Y, Huso D, Harrington J, Kellner J, Jeong D, Turney J . Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy. 2005; 7(6):509-19. DOI: 10.1080/14653240500363216. View